Finally one of the limitations of our study was the differences in incidence of diabetes mellitus and COPD in 3 groups, and further studies are recommended to determine the effects of these diseases on cTnT levels in CABG patients. The gene discussed is TNNT2; the disease is chronic obstructive pulmonary disease.